The Valley Desk

NCT01533207 · Interventional trial

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Overall registry status Terminated

Phase 3

Conditions Stage I Uterine Sarcoma AJCC v7, Uterine Corpus Leiomyosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov